SHARE PURCHASE AGREEMENTShare Purchase Agreement • July 20th, 2017 • Ossen Innovation Co. Ltd. • Steel works, blast furnaces & rolling mills (coke ovens) • New York
This Share Purchase Agreement (this “Agreement”) is made and entered into as of July 19, 2017 by and among (i) Elegant Kindness Limited, a business company incorporated in the British Virgin Islands with limited liability (the “Purchaser”), (ii) Liang Tang, the sole shareholder of the Purchaser (the “Shareholder”), (iii) Ossen Innovation Materials Group Co., Ltd., a business company incorporated in the British Virgin Islands with limited liability (the “Company”) and (iv) Ossen Innovation Co. Ltd. (the “Seller”). The Purchaser, the Shareholder, the Company and the Seller are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”.
SHARE EXCHANGE AGREEMENT by and among OSSEN INNOVATION CO. LTD., as the Purchaser, WEI HUA, as the OSN Representative, FASCINATING ACME DEVELOPMENT LIMITED, as representative for the OSN Management Indemnifying Parties AMERICA- ASIA DIABETES RESEARCH...Share Exchange Agreement • July 20th, 2017 • Ossen Innovation Co. Ltd. • Steel works, blast furnaces & rolling mills (coke ovens) • New York
This Share Exchange Agreement (this “Agreement”) is made and entered into as of July 19, 2017 by and among (i) Ossen Innovation Co., Ltd., a business company incorporated under the laws of the British Virgin Islands with limited liability (the “Purchaser”), (ii) Wei Hua, an individual residing in the People’s Republic of China, in the capacity as the representative from and after the Closing (as defined below) for the shareholders of the Purchaser as of immediately prior to the Closing in accordance with the terms and conditions of this Agreement (the “OSN Representative”), (iii) Fascinating Acme Development Limited, a British Virgin Islands company, in the capacity as representative of the OSN Management Indemnifying Parties in accordance with the terms and conditions of this Agreement (“FADL”), (iv) America-Asia Diabetes Research Foundation, a California corporation (the “Company”), (v) each of the shareholders of the Company named on Annex I hereto (collectively, the “Sellers”) and
